Citi Says Antitrust Risk Hangs Over $150 Billion in Drug Sales

Congress is hamstrung as it tries to cut the high cost of Americans’ prescription drugs, and so instead is likely to enact higher hurdles for deals, Citi said. That could hurt drugmakers as they face more than $150 billion in lost revenue as some key medicines face generic competition over the next 10 years, the bank cautioned.

• “Strong Republican support for antitrust enforcement against technology companies could increase the likelihood that the Democrats will find the support of the 10 Senate Republicans required for approval of Senator Klobuchar’s antitrust bill,” analysts led by Andrew Baum writes
• “Broader adoption of antitrust ...